메뉴 건너뛰기




Volumn 56, Issue SUPPL. 1, 2008, Pages 49-62

Phase III double-blind comparative study of sitafloxacin versus tosufloxacin in patients with community-acquired pneumonia

Author keywords

Community acquired pneumonia; Double blind study; Fluoroquinolone; Sitafloxacin; Tosufloxacin

Indexed keywords

MACROLIDE; SITAFLOXACIN; TOSUFLOXACIN;

EID: 43449113879     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (16)
  • 1
    • 0026719282 scopus 로고
    • Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates
    • Sato K, Hoshino K, Tanaka M, Hayakawa I, Osada Y: Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates. Antimicrob Agents Chemother 1992; 36:1491-8
    • (1992) Antimicrob Agents Chemother , vol.36 , pp. 1491-1498
    • Sato, K.1    Hoshino, K.2    Tanaka, M.3    Hayakawa, I.4    Osada, Y.5
  • 2
    • 43449113078 scopus 로고    scopus 로고
    • Japanese source.
    • Japanese source.
  • 4
    • 43449130536 scopus 로고    scopus 로고
    • Japanese source.
    • Japanese source.
  • 5
    • 43449083342 scopus 로고    scopus 로고
    • Japanese source.
    • Japanese source.
  • 6
    • 43449126051 scopus 로고    scopus 로고
    • Japanese source.
    • Japanese source.
  • 8
    • 0033053495 scopus 로고    scopus 로고
    • Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC , and parE loci
    • Jorgensen J H, Weigel L M, Ferraro M J, Swenson J M, Tenover F C: Activities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC , and parE loci. Antimicrob Agents Chemother 1999; 43: 329-34
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 329-334
    • Jorgensen, J.H.1    Weigel, L.M.2    Ferraro, M.J.3    Swenson, J.M.4    Tenover, F.C.5
  • 9
    • 8544271309 scopus 로고    scopus 로고
    • Performance standards for antimicrobial susceptibility testing
    • Clinical and Laboratory Standards Institute
    • Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; Seventeenth informational supplement. M100-S17; 2007
    • (2007) Seventeenth informational , Issue.SUPPL.EMENT. M100-S17
  • 10
    • 43449116482 scopus 로고    scopus 로고
    • Japanese source.
    • Japanese source.
  • 11
    • 43449108095 scopus 로고    scopus 로고
    • Japanese source.
    • Japanese source.
  • 12
    • 21144433018 scopus 로고    scopus 로고
    • New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance
    • Ferrara A M: New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance. Infection 2005; 33:106-14
    • (2005) Infection , vol.33 , pp. 106-114
    • Ferrara, A.M.1
  • 13
    • 0036783699 scopus 로고    scopus 로고
    • Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan
    • Yokota S, Sato K, Kuwahara O, Habadera S, Tsukamoto N, Ohuchi H, et al: Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan. Antimicrob Agents Chemother 2002; 46:3311-5
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 3311-3315
    • Yokota, S.1    Sato, K.2    Kuwahara, O.3    Habadera, S.4    Tsukamoto, N.5    Ohuchi, H.6
  • 14
    • 43449103448 scopus 로고    scopus 로고
    • Japanese source.
    • Japanese source.
  • 15
    • 43449133688 scopus 로고    scopus 로고
    • Japanese source.
    • Japanese source.
  • 16
    • 0035885054 scopus 로고    scopus 로고
    • Does the dose matter?
    • Craig W A: Does the dose matter? Clin Infect Dis 2001; 33: S233-7
    • (2001) Clin Infect Dis , vol.33
    • Craig, W.A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.